Annual Reports

 
Quarterly Reports

  • 10-Q (Nov 3, 2017)
  • 10-Q (Aug 3, 2017)
  • 10-Q (May 3, 2017)
  • 10-Q (Oct 28, 2016)
  • 10-Q (Apr 29, 2016)
  • 10-Q (Oct 30, 2015)

 
8-K

 
Other

Nanometrics 10-Q 2014

Documents found in this filing:

  1. 10-Q
  2. Ex-31.1
  3. Ex-31.2
  4. Ex-32.1
  5. Ex-32.1
Q2'2014 6.28.14

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
___________________________ 
FORM 10-Q
_____________________________________ 

(Mark One)
x
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended June 28, 2014
OR
o
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from              to             
Commission file number 0-13470 
___________________________________
NANOMETRICS INCORPORATED
(Exact name of registrant as specified in its charter)
__________________________________ 
Delaware
 
94-2276314
(State or other jurisdiction of
incorporation or organization)
 
(I. R. S. Employer
Identification No.)
1550 Buckeye Drive, Milpitas, CA
 
95035
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (408) 545-6000 
___________________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  Q    No  £
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or such shorter period that the registrant was required to submit and post such file)    Yes  Q    No  £
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
o
  
Accelerated filer
x
 
Non-accelerated filer
 
o (Do not check if a smaller reporting company)
  
Smaller reporting company
 o
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes   o  No  x
As of July 25, 2014, there were 24,123,337 shares of common stock, $0.001 par value, issued and outstanding.



NANOMETRICS INCORPORATED
INDEX TO QUARTERLY REPORT ON FORM 10-Q
FOR QUARTER ENDED JUNE 28, 2014
 
 
 
 
Page
 
 
 
 
 
Item 1.
 
 
 
 
 
 
Condensed Consolidated Balance Sheets as of June 28, 2014 and December 28, 2013 (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Six Month Periods Ended June 28, 2014 and June 29, 2013 (Unaudited)
 
 
 
 
 
 
Condensed Consolidated Statements of Cash Flows for the Six Month Periods Ended June 28, 2014 and June 29, 2013 (Unaudited)
 
 
 
 
 
 
 
 
 
 
 
Item 2.
21
 
 
 
 
 
Item 3.
 
 
 
 
 
Item 4.
 
 
 
 
 
 
 
Item 1A.
 
 
 
 
 
Item 6.
 
 
 
 
 


2


PART I — FINANCIAL INFORMATION
 
ITEM 1.
FINANCIAL STATEMENTS

NANOMETRICS INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited) 
 
June 28,
2014
 
December 28,
2013
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
37,987

 
$
44,765

Marketable securities
49,374

 
48,097

Accounts receivable, net of allowances of $295 and $293, respectively
33,458

 
31,436

Inventories
37,753

 
34,520

Inventories-delivered systems
358

 
6,901

Prepaid expenses and other
9,911

 
10,519

Deferred income tax assets
14,054

 
14,516

Total current assets
182,895

 
190,754

Property, plant and equipment, net
47,244

 
47,439

Goodwill
11,677

 
11,743

Intangible assets, net
6,280

 
7,864

Deferred income tax assets
4,344

 
4,338

Other assets
679

 
696

Total assets
$
253,119

 
$
262,834

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
6,982

 
$
10,604

Accrued payroll and related expenses
8,059

 
7,853

Deferred revenue
7,870

 
21,749

Other current liabilities
8,348

 
7,993

Income taxes payable
121

 
758

Total current liabilities
31,380

 
48,957

Deferred revenue
2,626

 
3,718

Income taxes payable
615

 
1,171

Other long-term liabilities
1,603

 
1,615

Total liabilities
36,224

 
55,461

Commitments and contingencies (Note 16)


 


Stockholders’ equity:
 
 
 
Preferred stock, $0.001 par value; 3,000,000 shares authorized; no shares issued or outstanding

 

Common stock, $0.001 par value, 47,000,000 shares authorized; 24,029,033 shares and 23,537,275 shares, respectively, issued and outstanding
24

 
24

Additional paid-in capital
251,679

 
244,733

Accumulated deficit
(35,813
)
 
(37,996
)
Accumulated other comprehensive income
1,005

 
612

Total stockholders’ equity
216,895

 
207,373

Total liabilities and stockholders’ equity
$
253,119

 
$
262,834

See Notes to Condensed Consolidated Financial Statements

3



NANOMETRICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited) 
 
Three Months Ended
 
Six Months Ended
 
June 28, 2014
 
June 29, 2013
 
June 28, 2014
 
June 29, 2013
Net revenues:
 
 
 
 
 
 
 
Products
$
39,224

 
$
26,533

 
$
82,504

 
$
39,612

Service
8,805

 
8,019

 
17,101

 
19,492

Total net revenues
48,029

 
34,552

 
99,605

 
59,104

Costs of net revenues:

 

 

 

Cost of products
19,789

 
14,832

 
41,428

 
22,792

Cost of service
4,655

 
4,593

 
9,769

 
10,041

Amortization of intangible assets
677

 
647

 
1,351

 
1,305

Total costs of net revenues
25,121

 
20,072

 
52,548

 
34,138

Gross profit
22,908

 
14,480

 
47,057

 
24,966

Operating expenses:
 
 

 

 

Research and development
9,373

 
8,321

 
17,687

 
15,768

Selling
6,681

 
6,613

 
14,054

 
13,545

General and administrative
6,001

 
5,507

 
12,339

 
11,019

Amortization of intangible assets
107

 
195

 
215

 
393

Total operating expenses
22,162

 
20,636

 
44,295

 
40,725

Income (loss) from operations
746

 
(6,156
)
 
2,762

 
(15,759
)
Other income (expense):


 


 


 


Interest income
10

 
20

 
24

 
45

Interest expense
(96
)
 
(205
)
 
(196
)
 
(431
)
Other income (expense), net
(84
)
 
(637
)
 
168

 
(597
)
Total other income (expense), net
(170
)
 
(822
)
 
(4
)
 
(983
)
Income (loss) before income taxes
576

 
(6,978
)
 
2,758

 
(16,742
)
Provision for (benefit from) income taxes
(12
)
 
(2,412
)
 
575

 
(6,594
)
Net income (loss)
$
588

 
$
(4,566
)
 
$
2,183

 
$
(10,148
)
Net income (loss) per share:
 
 


 


 


Basic
$
0.02

 
$
(0.20
)
 
$
0.09

 
$
(0.44
)
Diluted
$
0.02

 
$
(0.20
)
 
$
0.09

 
$
(0.44
)
Weighted shares used in per share calculation:
 
 
 
 


 


Basic
23,939

 
23,138

 
23,825

 
23,240

Diluted
24,220

 
23,138

 
24,217

 
23,240

See Notes to Condensed Consolidated Financial Statements

4


NANOMETRICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
(Unaudited) 

 
Three Months Ended
 
Six Months Ended
 
June 28, 2014
 
June 29, 2013
 
June 28, 2014
 
June 29, 2013
Net income (loss)
$
588

 
$
(4,566
)
 
$
2,183

 
$
(10,148
)
Other comprehensive income (loss):
 
 
 
 
 
 
 
Change in foreign currency translation adjustment
174

 
(35
)
 
385

 
(1,979
)
Net change on unrealized gains on available-for-sale investments
8

 
(8
)
 
8

 
(3
)
Other comprehensive income (loss)
182

 
(43
)
 
393

 
(1,982
)
Comprehensive income (loss)
$
770

 
$
(4,609
)
 
$
2,576

 
$
(12,130
)

See Notes to Condensed Consolidated Financial Statements


5


NANOMETRICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
Six Months Ended
 
June 28,
2014
 
June 29,
2013
Cash flows from operating activities:
 
 
 
Net income (loss)
$
2,183

 
$
(10,148
)
Reconciliation of net income (loss) to net cash used in operating activities:

 
 
Depreciation and amortization
4,814

 
4,268

Stock-based compensation
3,410

 
3,208

Excess tax benefit from equity awards

 
367

Loss on disposal of fixed assets
28

 
10

Inventory write-down
1,527

 
2,764

Deferred income taxes
490

 
(6,657
)
Changes in fair value of contingent consideration
66

 
1,000

Changes in assets and liabilities:
 
 
 
Accounts receivable
(1,909
)
 
(11,095
)
Inventories
(3,830
)
 
(4,121
)
Inventories-delivered systems
6,543

 
(170
)
Prepaid expenses and other
1,251

 
(109
)
Accounts payable, accrued and other liabilities
(2,961
)
 
1,566

Deferred revenue
(14,978
)
 
2,548

Income taxes payable
(1,203
)
 
(389
)
Net cash used in operating activities
(4,569
)
 
(16,958
)
Cash flows from investing activities:
 
 
 
Maturities of marketable securities
17,620

 
22,788

Purchases of marketable securities
(19,479
)
 
(23,454
)
Purchases of property, plant and equipment
(3,813
)
 
(1,970
)
Net cash used in investing activities
(5,672
)
 
(2,636
)
Cash flows from financing activities:
 
 
 
Payments of contingent consideration
(261
)
 
(216
)
Repayments of debt obligations

 
(456
)
Proceeds from sale of shares under employee stock option and purchase plans
4,201

 
2,858

Excess tax benefit from equity awards

 
(367
)
Taxes paid on net issuance of stock awards
(664
)
 
(86
)
Repurchases of common stock

 
(5,000
)
Net cash provided by (used in) financing activities
3,276

 
(3,267
)
Effect of exchange rate changes on cash and cash equivalents
187

 
(952
)
Net decrease in cash and cash equivalents
(6,778
)
 
(23,813
)
Cash and cash equivalents, beginning of period
44,765

 
62,915

Cash and cash equivalents, end of period
$
37,987

 
$
39,102

See Notes to Condensed Consolidated Financial Statements

6


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1. Nature of Business and Basis of Presentation

Description of Business – Nanometrics Incorporated (“Nanometrics” or the “Company”) and its wholly-owned subsidiaries, design, manufacture, market, sell and support thin film, optical critical dimension and overlay dimension metrology and inspection systems used primarily in the manufacturing of semiconductors, solar photovoltaics (“solar PV”) and high-brightness LEDs (“HB-LED”), as well as by customers in the silicon wafer and data storage industries. Nanometrics' metrology systems precisely measure a wide range of film types deposited on substrates during manufacturing to control manufacturing processes and increase production yields in the fabrication of integrated circuits. The thin film metrology systems use a broad spectrum of wavelengths, high-sensitivity optics, proprietary software, and patented technology to measure the thickness and uniformity of films deposited on silicon and other substrates as well as their chemical composition. The Company’s optical critical dimension technology is a patented critical dimension measurement technology that is used to precisely determine the dimensions on the semiconductor wafer that directly control the resulting performance of the integrated circuit devices. The overlay metrology systems are used to measure the overlay accuracy of successive layers of semiconductor patterns on wafers in the photolithography process. Nanometrics' inspection systems are used to find defects on patterned and unpatterned wafers at nearly every stage of the semiconductor production flow. The corporate headquarters of Nanometrics is located in Milpitas, California.
    
Basis of Presentation – The accompanying condensed consolidated financial statements ("financial statements") have been prepared on a consistent basis with the audited consolidated financial statements as of December 28, 2013, and include all normal recurring adjustments necessary to fairly present the information set forth therein. All significant intercompany accounts and transactions have been eliminated in consolidation.
The financial statements have been prepared in accordance with the regulations of the United States Securities and Exchange Commission (“SEC”) for interim periods in accordance with S-X Article 10, and, therefore, omit certain information and footnote disclosure necessary to present the statements in accordance with accounting principles generally accepted in the United States of America. The operating results for interim periods are not necessarily indicative of the operating results that may be expected for the entire year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended December 28, 2013, which were included in the Company’s Annual Report on Form 10-K filed with the SEC on March 7, 2014.

Fiscal Period – The Company uses a 52/53 week fiscal year ending on the Saturday nearest to December 31. All references to the quarter refer to Nanometrics' fiscal quarter. The fiscal quarters presented herein include 13 weeks.

Reclassification – Certain prior year amounts have been reclassified to conform to the current year presentation.

Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates. Estimates are used for, but not limited to, revenue recognition, the provision for doubtful accounts, the provision for excess, obsolete, or slow moving inventories, valuation of intangible and long-lived assets, warranty accruals, income taxes, valuation of stock-based compensation and contingencies.

Revenue Recognition – The Company derives revenue from the sale of process control metrology systems (“product revenue”) as well as spare part sales, billable service, service contracts and upgrades (together “service revenue”). Upgrades are a group of parts and/or software that change the existing configuration of a product and are included in service revenue. They are distinguished from product revenue, which consists of complete, advanced process control metrology and inspection systems (the “system(s)”). Nanometrics' systems consist of hardware and software components that function together to deliver the essential functionality of the system. Arrangements for sales of systems often include defined customer-specified acceptance criteria.

In summary, the Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller's price is fixed or determinable, and collectability is reasonably assured.


7


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


For product sales to existing customers, revenue recognition occurs at the time title and risk of loss transfer to the customer, which usually occurs upon shipment from the Company's manufacturing location, if it can be reliably demonstrated that the product has successfully met the defined customer specified acceptance criteria and all other recognition criteria has been met. For initial sales where the product has not previously met the defined customer specified acceptance criteria, product revenues are recognized upon the earlier of receipt of written customer acceptance or expiration of the contractual acceptance period. In Japan, where contractual terms with the customer specify risk of loss and title transfers upon customer acceptance, revenue is recognized upon receipt of written customer acceptance, provided that all other recognition criteria have been met.

The Company warrants its products against defects in manufacturing. Upon recognition of product revenue, a liability is recorded for anticipated warranty costs. On occasion, customers request a warranty period longer than the Company's standard warranty. In those instances where extended warranty services are separately quoted to the customer, the associated revenue is deferred and recognized as service revenue ratably over the term of the contract. The portion of service contracts and extended warranty services agreements that are uncompleted at the end of any reporting period are included in deferred revenue.

As part of its customer services, the Company sells software that is considered to be an upgrade to a customer's existing systems. These standalone software upgrades are not essential to the tangible product's functionality and are accounted for under software revenue recognition rules which require vendor specific objective evidence ("VSOE") of fair value to allocate revenue in a multiple element arrangement. Revenue from upgrades is recognized when the upgrades are delivered to the customer, provided that all other recognition criteria have been met.
    
Revenue related to spare parts is recognized upon shipment. Revenue related to billable services is recognized as the services are performed. Service contracts may be purchased by the customer during or after the warranty period and revenue is recognized ratably over the service contract period.

Frequently, the Company delivers products and various services in a single transaction. The Company's deliverables consist of tools, installation, upgrades, billable services, spare parts, and service contracts. The Company's typical multi-element arrangements include a sale of one or multiple tools that include installation and standard warranty. Other arrangements consist of a sale of tools bundled with service elements or delivery of different types of services. The Company's tools, upgrades, and spare parts are generally delivered to customers within a period of up to six months from order date. Installation is usually performed soon after delivery of the tool. The portion of revenue associated with installation is deferred based on relative selling price and that revenue is recognized upon completion of the installation. Billable services are billed on a time and materials basis and performed as requested by customers. Under service contract arrangements, services are provided as needed over the fixed arrangement term. The Company does not grant its customers a general right of return or any refund terms and imposes a penalty on orders canceled prior to the scheduled shipment date.

The Company regularly evaluates its revenue arrangements to identify deliverables and to determine whether these deliverables are separable into multiple units of accounting. In accordance with revenue recognition guidance, the Company allocates the arrangement consideration among the deliverables based on relative selling prices. The Company has established VSOE for some of its products and services when a substantial majority of selling prices falls within a narrow range when sold separately. For deliverables with no established VSOE, the Company uses best estimate of selling price to determine standalone selling price for such deliverable. The Company does not use third party evidence ("TPE") to determine standalone selling price since this information is not widely available in the market as the Company's products contain a significant element of proprietary technology and the solutions offered differ substantially from competitors. The Company has established a process for developing estimated selling prices, which incorporates historical selling prices, the effect of market conditions, gross margin objectives, pricing practices, as well as entity-specific factors. The Company monitors and evaluates estimated selling price on a regular basis to ensure that changes in circumstances are accounted for in a timely manner.
When certain elements in multiple-element arrangements are not delivered or accepted at the end of a reporting period, the relative selling prices of undelivered elements are deferred until these elements are delivered and/or accepted. If deliverables cannot be accounted for as separate units of accounting, the entire arrangement is accounted for as a single unit of accounting and revenue is deferred until all elements are delivered and all revenue recognition requirements are met.



8


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


Note 2. Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force) ("ASU 2013-11"), which provides that a liability related to an unrecognized tax benefit would be offset against a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations in which a net operating loss carryforward, a similar tax loss or a tax credit carryforward is not available at the reporting date under the tax law of the jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit will be presented in the financial statements as a liability and will not be combined with deferred tax assets. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. ASU 2013-11 is effective for fiscal years and interim periods beginning after December 15, 2013. The Company adopted this standard during the three months ended March 29, 2014, resulting in a one-time tax benefit of $0.3 million, a reduction in deferred tax assets of $0.3 million, and a reduction in long-term income taxes payable of $0.6 million.
In May 2014, the Financial Accountings Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The standard will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

Note 3. Fair Value Measurements and Disclosures
Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability, and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability.
The Company determines the fair values of its financial instruments based on the fair value hierarchy established in ASC 820, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into the following three levels that may be used to measure fair value:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.
Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Such unobservable inputs include an estimated discount rate used in the Company's discounted present value analysis of future cash flows, which reflects the Company's estimate of debt with similar terms in the current credit markets. As there is currently minimal activity in such markets, the actual rate could be materially different.
 

9


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)



The following tables present the Company’s assets and liabilities measured at estimated fair value on a recurring basis, excluding accrued interest components, categorized in accordance with the fair value hierarchy (in thousands), as of the following dates:
 
June 28, 2014
 
December 28, 2013
 
Fair Value Measurements Using Input Types
 
 
 
Fair Value Measurements Using Input Types
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
$
403

 
$

 
$

 
$
403

 
$
876

 
$

 
$

 
$
876

Commercial paper

 

 

 

 

 
750

 

 
750

    Total cash equivalents
403

 

 

 
403

 
876

 
750

 

 
1,626

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Marketable securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury, U.S. Government and U.S. Government agency debt securities
5,009

 
13,416

 

 
18,425

 
5,036

 
11,980

 

 
17,016

Commercial paper, municipal securities and corporate debt securities

 
30,949

 

 
30,949

 

 
31,081

 

 
31,081

    Total marketable securities
5,009

 
44,365

 

 
49,374

 
5,036

 
43,061

 

 
48,097

Total (1)
$
5,412

 
$
44,365

 
$

 
$
49,777

 
$
5,912

 
$
43,811

 
$

 
$
49,723

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent consideration payable
$

 
$

 
$
2,588

 
$
2,588

 
$

 
$

 
$
2,783

 
$
2,783


(1) Excludes cash of $37.6 million and $43.1 million held in operating accounts as of June 28, 2014 and December 28, 2013, respectively.
The fair values of the marketable securities that are classified as Level 1 in the table above were derived from quoted market prices for identical assets or liabilities that the Company has the ability to access. The fair value of marketable securities that are classified as Level 2 in the table above were derived from: non-binding market consensus prices that were corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques, with all significant inputs derived from or corroborated by observable market data. There were no transfers of instruments between Level 1, Level 2 and Level 3 during the financial periods presented.
    
Changes in Level 3 liabilities (in thousands)
 
Fair value at December 28, 2013
$
2,783

Payments made to Zygo Corporation
(261
)
Change in fair value included in earnings
66

Fair Value at June 28, 2014
$
2,588

As of June 28, 2014, the Company had liabilities of $2.6 million resulting from the acquisition of certain assets from Zygo Corporation (“Zygo”), which are measured at fair value on a recurring basis, with changes in fair value recorded in other income (expense), net. Of the $2.6 million of Zygo liabilities at June 28, 2014, $1.2 million was a current liability and $1.4 million was a long-term liability. As of December 28, 2013, the liabilities totaled $2.8 million of which $1.3 million was a current liability and $1.5 million was a long-term liability. The fair values of these liabilities were determined using Level 3 inputs applying a discounted cash flow model incorporating assumptions that market participants would use in their estimates of fair value. Some of these assumptions included estimates for discount rate, and timing and the amount of cash flows.




10


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)



Note 4. Cash and Investments
    
The following table presents cash, cash equivalents, and available-for-sale investments as of the following dates (in thousands):
 
June 28, 2014
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Estimated Fair Market Value
Cash
$
37,584

 

 
$

 
$
37,584

Cash equivalents:
 
 
 
 
 
 
 
Money market funds
403

 

 

 
403

Marketable securities:
 
 
 
 
 
 
 
Commercial paper
999

 

 

 
999

U.S. Treasury securities
5,008

 
1

 

 
5,009

U.S. Government agency securities
13,412

 
6

 
(2
)
 
13,416

Municipal securities
8,228

 
5

 
(1
)
 
8,232

Corporate debt securities
21,710

 
14

 
(6
)
 
21,718

Total cash, cash equivalents, and marketable securities
$
87,344

 
$
26

 
$
(9
)
 
$
87,361

 
 
 
 
 
 
 
 
 
December 28, 2013
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Estimated Fair Market Value
Cash
$
43,139

 
$

 
$

 
$
43,139

Cash equivalents:
 
 
 
 
 
 
 
Money market funds
876

 

 

 
876

Commercial paper
750

 

 

 
750

Marketable securities:
 
 
 
 
 
 
 
U.S. Treasury Securities
5,036

 

 

 
5,036

U.S. Government agency securities
11,980

 
4

 
(4
)
 
11,980

Municipal securities
9,756

 
11

 
(4
)
 
9,763

Corporate debt securities
21,316

 
7

 
(5
)
 
21,318

Total cash, cash equivalents, and marketable securities
$
92,853

 
$
22

 
$
(13
)
 
$
92,862

 
 
 
 
 
 
 
 

Available-for-sale marketable securities, readily convertible to cash, with maturity dates of 90 days or less are classified as cash equivalents, while those with maturity dates greater than 90 days are classified as marketable securities within short-term assets. All marketable securities as of June 28, 2014 and December 28, 2013, were available-for-sale and reported at fair value based on the estimated or quoted market prices as of the balance sheet date. Unrealized gains or losses, net of tax effect, are recorded in accumulated other comprehensive income (loss) within stockholders' equity. Both the gross unrealized gains and gross unrealized losses for the three and six months ended June 28, 2014 and June 29, 2013, were insignificant and no

11


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


marketable securities had other than temporary impairment. All marketable securities as of June 28, 2014 and December 28, 2013, had maturity dates of less than two years and were not invested in foreign entities.

Note 5. Accounts Receivable

The Company maintains arrangements under which eligible accounts receivables in Japan are sold without recourse to unrelated third party financial institutions. These receivables were not included in the consolidated balance sheets as the criteria for sale treatment had been met. The Company pays administrative fees as well as interest ranging in total from 1.23% to 1.68% based on the anticipated length of time between the date the sale is consummated and the expected collection date of the receivables sold. The Company sold $1.0 million and $3.2 million of receivables during the three months ended June 28, 2014 and June 29, 2013, respectively, and sold $1.5 million and $4.6 million of receivables during the six months ended June 28, 2014 and June 29, 2013, respectively. There were no material gains or losses on the sale of such receivables. There were no amounts due from such third party financial institutions at June 28, 2014 and December 28, 2013, respectively.

Note 6. Inventories
Inventories are stated at the lower of standard cost (which approximates actual cost on a first-in, first-out basis) or market. Inventories consist of the following as of the following dates (in thousands):
 
 
June 28,
2014
 
December 28,
2013
Raw materials and sub-assemblies
$
20,754

 
$
19,655

Work in process
8,943

 
7,597

Finished goods
8,056

 
7,268

Inventories
37,753

 
34,520

Inventories-delivered systems
358

 
6,901

Total inventories
$
38,111

 
$
41,421


The Company reflects the cost of systems that were invoiced upon shipment but deferred for revenue recognition purposes separate from its inventory held for sale as "Inventories-delivered systems."

Note 7. Property, Plant and Equipment
Property, plant and equipment, net, consist of the following as of the following dates (in thousands):
 
June 28, 2014
 
December 28, 2013
Land
$
15,575

 
$
15,569

Building and improvements
19,803

 
19,403

Machinery and equipment
28,146

 
27,820

Furniture and fixtures
2,362

 
2,308

Software
7,810

 
1,851

Capital in progress
1,533

 
5,833

Total property, plant and equipment, gross
75,229

 
72,784

Accumulated depreciation and amortization
(27,985
)
 
(25,345
)
Total property, plant and equipment, net
$
47,244

 
$
47,439

Total depreciation and amortization expense for the three months ended June 28, 2014 and June 29, 2013, was $1.6 million and $1.3 million, respectively. Total depreciation and amortization expense for the six months ended June 28, 2014 and June 29, 2013, was $3.2 million and $2.6 million, respectively.



12


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)



Note 8. Goodwill and Intangible Assets

The following table summarizes the activity in the Company’s goodwill during the six months ended June 28, 2014 (in thousands):

 
 
Balance as of December 28, 2013
$
11,743

      Foreign currency movements
(66
)
Balance as of June 28, 2014
$
11,677

Finite-lived intangible assets are recorded at cost, less accumulated amortization. Finite-lived intangible assets consisted of the following as of the following dates (in thousands):

 
 
June 28, 2014
 
Adjusted cost
 
Accumulated amortization
 
Net carrying amount
Developed technology
$
18,060

 
$
(12,334
)
 
$
5,726

Customer relationships
9,567

 
(9,420
)
 
147

Brand names
1,927

 
(1,751
)
 
176

Patented technology
2,252

 
(2,021
)
 
231

Trademark
80

 
(80
)
 


$
31,886

 
$
(25,606
)
 
$
6,280


 
 
December 28, 2013
 
Adjusted cost
 
Accumulated amortization
 
Net carrying amount
Developed technology
$
18,095

 
$
(11,032
)
 
$
7,063

Customer relationships
9,573

 
(9,263
)
 
310

Brand names
1,927

 
(1,700
)
 
227

Patented technology
2,252

 
(1,988
)
 
264

Trademark
80

 
(80
)
 


$
31,927

 
$
(24,063
)
 
$
7,864


The amortization of finite-lived intangibles is computed using the straight-line method. Estimated lives of finite-lived intangibles range from 2 to 10 years. Total amortization expense for each of the three months ended June 28, 2014 and June 29, 2013 was $0.8 million and $0.8 million, respectively. Total amortization expense for each of the six months ended June 28, 2014 and June 29, 2013, was $1.6 million and $1.7 million, respectively.

13


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)



At June 28, 2014, estimated future amortization expense of intangible assets were as follows (in thousands):
 
Fiscal years
 
Amount
2014 (remaining six months)
 
$
1,536

2015
 
2,392

2016
 
1,940

2017
 
206

2018
 
140

Thereafter
 
66

    Total future amortization expense
 
$
6,280


Note 9. Other Current Liabilities
Other current liabilities consist of the following as of the following dates (in thousands):
 
June 28,
2014
 
December 28,
2013
Accrued warranty
$
3,484

 
$
3,426

Accrued professional services
712

 
545

Customer deposits
930

 
867

Fair value of contingent payments to Zygo Corporation related to acquisition - current portion
1,157

 
1,344

Other
2,065

 
1,811

Total other current liabilities
$
8,348

 
$
7,993



Note 10. Line of Credit and Debt Obligations
 
Line of Credit - On May 30, 2014, the Company amended its revolving line of credit facility (i) to extend the maturity date of such facility by two years to May 30, 2016, and (ii) to increase the minimum amount available to borrow to $12.0 million. The instrument governing the line of credit facility includes certain financial covenants regarding tangible net worth. The revolving line of credit agreement includes a provision for the issuance of commercial or standby letters of credit by the bank on behalf of the Company. The value of all letters of credit outstanding reduces the total line of credit available. The revolving line of credit is collateralized by a blanket lien on all of the Company’s domestic assets excluding intellectual property and real estate. The minimum borrowing interest rate is 3.00% per annum. Borrowing is limited to the lesser of (a) $12.0 million plus the borrowing base, or (b) $20.0 million. The total borrowing available as of June 28, 2014, was $17.6 million. As of June 28, 2014, the Company was not in breach of any restrictive covenants in connection with this line of credit. There were no outstanding amounts drawn on this facility as of June 28, 2014. Although management has no current plans to request advances under this credit facility, the Company may use the proceeds of any future borrowing for general corporate purposes, future acquisitions or expansion of the Company's business.

Mortgage Loan - In July 2008, the Company entered into a mortgage loan agreement with General Electric Commercial Finance ("GE") pursuant to which it borrowed $13.5 million, secured, in part, by a lien on and security interest in the building and land comprising the Company's principal offices in Milpitas, California. The loan initially bore interest at the rate of 7.18% per annum, which rate was scheduled to reset in August 2013 to 3.03% over the weekly average yield of five-year U.S Dollar Interest Rate Swaps as published by the Federal Reserve. Monthly principal and interest payments were based on a 20 year amortization for the first 60 months and 15 year amortization thereafter. The remaining principal balance of the loan and any accrued but unpaid interest will be due on August 1, 2018. According to the terms of the loan agreement, the Company could make annual pre-payments of up to 20% of the outstanding principal balance without incurring any penalty. GE subsequently sold the mortgage on March 31, 2011 to Sterling Saving Bank; however, no changes were made to the terms of the original loan agreement with GE as a result of the sale. In July 2012, the Company prepaid $1.4 million of the loan, representing 20% of the outstanding balance at the time of prepayment. On July 18, 2013, the Company repaid $4.8 million of the loan, representing the entire outstanding principal balance of the loan and all accrued interest. The Company did not incur any fees associated with

14


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


the prepayment of the loan. As of June 28, 2014, there was no outstanding balance and no available amounts to borrow on the loan.
 
Note 11. Net Income (Loss) Per Share
    
The Company presents both basic and diluted net income (loss) per share on the face of its condensed consolidated statements of operations. Basic net income (loss) per share are computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding for the period. Diluted net income (loss) per share are computed using the weighted-average number of shares of common stock outstanding plus the effect of all dilutive securities representing potential shares of common stock outstanding during the period.
A reconciliation of the share denominator of the basic and diluted net income (loss) per share computations for the three and six months ended June 28, 2014 and June 29, 2013, is as follows (in thousands):


 
 
Three Months Ended
 
Six Months Ended
 
 
 
June 28, 2014
 
June 29, 2013
 
June 28, 2014
 
June 29, 2013
Weighted average common shares outstanding used in basic net income (loss) per share calculation
23,939

 
23,138

 
23,825

 
23,240

Dilutive common stock equivalents, using treasury stock method
281

 

 
392

 

Shares used in diluted net income (loss) per share computation
24,220

 
23,138

 
24,217

 
23,240


The Company excluded an insignificant amount of ESPP shares for the six months ended June 28, 2014, since their inclusion would have been anti-dilutive. Since the Company had a net loss for the three and six months ended June 29, 2013, potentially dilutive securities of 0.4 million shares were not included in the computation of diluted shares for each period since inclusion of such shares would have been anti-dilutive. Accordingly, basic and diluted net loss per share were the same for the three and six months ending June 29, 2013.    

Note 12. Equity and Stock Based Compensation Plans
Options
The fair value of each option award is estimated on the date of grant using the Black-Scholes valuation model and the assumptions noted in the following table. The expected life of options granted was calculated using the simplified method. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of the Company's stock price. The dividend yield reflects that the Company has not paid any cash dividends since inception and does not intend to pay any cash dividends in the foreseeable future.
 
Three Months Ended
 
Six Months Ended
 
June 28,
2014
 
June 29,
2013
 
June 28,
2014
 
June 29,
2013
Stock Options
 
 
 
 
 
 
 
Expected life
4.6 years

 
4.6 years

 
4.6 years

 
4.5 years

Expected volatility
52.00
%
 
68.90
%
 
54.86
%
 
72.32
%
Risk-free interest rate
1.56
%
 
1.02
%
 
1.54
%
 
0.90
%
Dividends

 

 

 

Employee Stock Purchase Plan
 
 
 
 
 
 
 
Expected life
0.5 years

 
0.5 years

 
0.5 years

 
0.5 years

Expected volatility
32.60
%
 
25.94
%
 
32.60
%
 
27.61
%
Risk-free interest rate
1.00
%
 
0.10
%
 
1.00
%
 
0.11
%
Dividends

 

 

 


15


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


The weighted average fair value per share of the stock options awarded in the three months ended June 28, 2014 and June 29, 2013, was $7.30 and $7.94, respectively, and in the six months ended June 28, 2014 and June 29, 2013, was $8.13 and $8.70, respectively, based on the fair market value of the Company’s common stock on the grant dates.
A summary of activity under the Company’s stock option plans during the six months ended June 28, 2014 is as follows:
 
Number of
Shares
Outstanding
(Options)
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual Term (Years)
 
Aggregate Intrinsic Value (in Thousands)
Options:
 
 
 
 
 
 
 
Outstanding at December 28, 2013
1,909,039

 
$
13.22

 
4.02

 
$
10,341

Exercised
(327,466
)
 
$
10.39

 
 
 
 
Granted
74,300

 
$
17.56

 
 
 
 
Cancelled
(70,688
)
 
$
15.42

 
 
 
 
Outstanding at June 28, 2014
1,585,185

 
$
13.91

 
3.96

 
$
7,139

Exercisable at June 28, 2014
1,028,377

 
$
12.73

 
3.17

 
$
5,840

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on the Company’s closing stock price of $18.37 as of June 27, 2014, the last trading day of the quarter, which would have been received by the option holders had all option holders exercised their options as of that date. The total intrinsic value of options exercised during the three months ended June 28, 2014 and June 29, 2013, was $0.8 million and $0.6 million, respectively, and during the six months ended June 28, 2014 and June 29, 2013, was $2.5 million and $1.4 million, respectively.

Restricted Stock Units ("RSUs")
A summary of activity for RSUs during the six months ended June 28, 2014, is as follows:
 
Number
of RSUs
 
Weighted
Average Fair
Value
Outstanding RSUs at December 28, 2013
334,444

 
$
18.61

    Granted
385,385

 
$
17.65

    Released
(134,858
)
 
$
17.91

    Cancelled
(15,246
)
 
$
17.51

Outstanding RSUs at June 28, 2014
569,725

 
$
18.37


    

16


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


Stock-based Compensation Expense
Stock-based compensation expense for all share-based payment awards made to the Company’s employees and directors pursuant to the employee stock option and employee stock purchase plans by function was as follows (in thousands):
 
 
Three Months Ended
 
Six Months Ended
 
June 28,
2014

June 29,
2013
 
June 28,
2014
 
June 29,
2013
Cost of products
$
68

 
$
53

 
$
129

 
$
98

Cost of service
89

 
71

 
174

 
130

Research and development
296

 
362

 
636

 
679

Selling
437

 
501

 
863

 
941

General and administrative
886

 
764

 
1,608

 
1,360

Total stock-based compensation expense
$
1,776

 
$
1,751

 
$
3,410

 
$
3,208


Note 13. Components of Accumulated Other Comprehensive Income (Loss)

The following table shows a summary of changes in components of accumulated other comprehensive income (loss) for the six months ended June 28, 2014 (in thousands):

 
Defined Benefit Pension Plans
 
Foreign Currency Translations
 
Unrealized Gain on Investment
 
Total
Balance at December 28, 2013
$
(28
)
 
$
631

 
$
9

 
$
612

Other comprehensive income

 
385

 
8

 
393

Balance at June 28, 2014
$
(28
)
 
$
1,016

 
$
17

 
$
1,005



Note 14. Warranties
The Company sells the majority of its products with a 12 months repair or replacement warranty from the date of acceptance or shipment date. The Company provides an accrual for estimated future warranty costs based upon the historical relationship of warranty costs to the cost of products sold. The estimated future warranty obligations related to product sales are recorded in the period in which the related revenue is recognized. The estimated future warranty obligations are affected by the warranty periods, sales volumes, product failure rates, material usage, and labor and replacement costs incurred in correcting a product failure. If actual product failure rates, material usage, labor or replacement costs were to differ from the Company’s estimates, revisions to the estimated warranty obligations would be required. For new product introductions where limited or no historical information exists, the Company may use warranty information from other previous product introductions to guide it in estimating its warranty accrual. The warranty accrual represents the best estimate of the amount necessary to settle future and existing claims on products sold as of the balance sheet date. The Company periodically assesses the adequacy of its reported warranty reserve and adjusts such amounts in accordance with changes in these factors.

17


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


Components of the warranty accrual, which were included in the accompanying condensed consolidated balance sheets within other current liabilities, were as follows (in thousands):
 
 
Three Months Ended
 
Six Months Ended
 
June 28,
2014
 
June 29,
2013
 
June 28,
2014
 
June 29,
2013
Balance at beginning of the period
$
3,575

 
$
3,655

 
$
3,426

 
$
4,203

Accruals for warranties issued during period
913

 
701

 
2,013

 
1,124

Aggregate changes in liabilities related to preexisting warranties
993

 
386

 
1,204

 
603

Settlements during the period
(1,997
)
 
(1,223
)
 
(3,159
)
 
(2,411
)
Balance at end of the period
$
3,484

 
$
3,519

 
$
3,484

 
$
3,519



Note 15. Income Taxes

The Company accounts for income taxes under the provisions of ASC 740, Accounting for Income Taxes. The Company adjusts its effective tax rate each quarter to be consistent with the estimated annual effective tax rate. The Company also records the tax effect of unusual or infrequently occurring discrete items, including changes in judgment about valuation allowances and effects of changes in tax laws or tax rates, in the interim period in which they occur. The Company's effective tax rate reflects the impact of a portion of its earnings being taxed in foreign jurisdictions as well as a valuation allowance maintained on certain deferred tax assets.
The Company recorded a tax benefit of $0.01 million and $2.4 million for the three months ended June 28, 2014 and June 29, 2013, respectively, and a tax provision of $0.6 million and a tax benefit of $6.6 million for the six months ended June 28, 2014 and June 29, 2013, respectively. The change during the three months ended June 28, 2014, compared to the corresponding period in 2013, was primarily related to the increase in profitability of the Company during the three months ended June 28, 2014. The change during the six months ended June 28, 2014, compared to the corresponding period in 2013, was primarily related to the increase in profitability of the Company during the six months ended June 28, 2014, as well as a one-time benefit of $0.6 million recorded during the six months ended June 29, 2013 related to the retroactive reinstatement of the 2012 Federal R&D tax credit.
As of June 28, 2014, the Company continued to maintain a valuation allowance against certain net deferred tax assets as a result of uncertainties regarding the realization of the asset due to cumulative losses and uncertainty of future taxable income in various tax jurisdictions. In the event that the Company determines that the deferred tax assets are realizable, an adjustment to the valuation allowance will be reflected in the tax provision for the period such determination is made.
The Company is subject to taxation in the U.S. and various states including California, and foreign jurisdictions including South Korea, Japan and United Kingdom. Due to tax attribute carry-forwards, the Company is subject to examination for tax years from 2003 forward for U.S. tax purposes. The Company is also subject to examination in various states for tax years from 2002 forward. The Company is subject to examination for tax years from 2006 forward for various foreign jurisdictions.
On September 13, 2013, the U.S. Treasury Department and the IRS issued final regulations that address costs incurred in acquiring, producing, or improving tangible property (the "tangible property regulations"). The tangible property regulations are generally effective for tax years beginning on or after January 1, 2014, and may be adopted in earlier years. The tangible property regulations required the Company to make additional tax accounting method changes as of January 1, 2014. The impact of these changes was not material to the Company’s consolidated financial position or its results of operations.
The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. The total amount of accrued penalties and interest was immaterial for the three and six months ended June 28, 2014. During the next twelve months, the Company anticipates increases in its unrecognized tax benefits of approximately $0.3 million.




18


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


Note 16. Commitments and Contingencies

Intellectual Property Indemnification Obligations – The Company will, from time to time, in the normal course of business, agree to indemnify certain customers, vendors or others against third party claims that the Company’s products, when used for their intended purpose(s), or the Company's intellectual property, infringe the intellectual property rights of such third parties or other claims made against parties with which it enters into contractual relationships. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim. Historically, the Company has not made payments under these obligations and believes that the estimated fair value of these agreements is immaterial. Accordingly, no liabilities have been recorded for these obligations in the accompanying condensed consolidated balance sheets as of June 28, 2014 and December 28, 2013.    

Note 17. Geographic and Significant Customer Information
The Company has one operating segment, which is the sale, design, manufacture, marketing and support of thin film and optical critical dimension systems. The following tables summarize total net revenues (based on the deployments and service location of the systems) and long-lived assets (excluding intangible assets) attributed to significant geographic regions (in thousands):
 

 
Three Months Ended
 
Six Months Ended
 
June 28, 2014
 
June 29, 2013
 
June 28, 2014
 
June 29, 2013
United States
$
13,302

 
$
16,328

 
$
20,043

 
$
25,761

Japan
2,222

 
5,407

 
5,906

 
6,051

Taiwan
6,281

 
2,018

 
10,697

 
7,230

China
9,358

 
5,594

 
24,846

 
9,141

South Korea
8,373

 
506

 
24,262

 
761

Other
8,493

 
4,699

 
13,851

 
10,160

Total net revenues
$
48,029

 
$
34,552

 
$
99,605

 
$
59,104



 
At
 
June 28, 2014
 
December 28, 2013
United States
$
44,963

 
$
44,775

Japan
105

 
125

South Korea
383

 
445

All Other
1,793

 
2,094

Total long-lived tangible assets
$
47,244

 
$
47,439


The following customers accounted for 10% or more of total accounts receivable as of the following dates:
 
June 28, 2014
 
December 28, 2013
SK Hynix
24
%
 
22
%
Taiwan Semiconductor Mfg. Co.
17
%
 
12
%
Global Foundries
17
%
 
***

Samsung Electronics Co. Ltd.
***

 
27
%
Intel Corporation
***

 
14
%

     *** The customer accounted for less than 10% of total accounts receivable as of that period end.
    

19


NANOMETRICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(Unaudited)


The following customers accounted for 10% or more of total net revenues:
 
Three Months Ended
 
Six Months Ended
 
June 28,
2014
 
June 29,
2013
 
June 28,
2014
 
June 29,
2013
Intel Corporation
18
%
 
29
%
 
16
%
 
27
%
SK Hynix
18
%
 
23
%
 
13
%
 
15
%
Samsung Electronics Co. Ltd.
16
%
 
15
%
 
35
%
 
12
%
Global Foundries
15
%
 
***

 
***

 
***

Taiwan Semiconductor Mfg. Co.
11
%
 
***

 
***

 
***


     *** The customer accounted for less than 10% of total net revenues for that period.

Note 18. Subsequent Event
In July 2014, the Company communicated a plan to consolidate a portion of its European operations to maximize efficiencies. The Company anticipates recording a charge related to employee involuntary termination benefits of approximately $0.7 million. The Company will incur additional charges related to a facility lease which currently expires in 2017. The Company will measure and recognize the exit liability associated with this lease at the cease-use date. The Company expects to complete this restructuring plan by March 2015. Other related costs will be recognized as incurred.



20



ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. The statements contained in this document that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, including, without limitation, statements regarding future periods, financial results, revenues, margins, growth, customers, tax rates, product performance, and the impact of accounting rules on our business and the future implications of our statements regarding goals, strategy, and similar terms. We may identify these statements by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” "intend," "likely," “may,” “might,” "plan," "potential," "predict," "project," "should," “will,” "would," and other similar expressions. All forward-looking statements included in this document are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements, except as may otherwise be required by law.
Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain risks, uncertainties and changes in circumstances, many of which may be difficult to predict or beyond our control, including those factors referenced in Part II, Item 1A, Risk Factors, and elsewhere in this document, and in Part I, Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended December 28, 2013. In particular our results could vary significantly based on: changes in customer and industry spending; rate and extent of changes in product mix; adoption of new products; timing of orders, shipments, and acceptance of products; our ability to secure volume supply agreements; and general economic conditions. In evaluating our business, investors should carefully consider these factors in addition to any other risks and uncertainties set forth elsewhere. The occurrence of the events described in the risk factors and elsewhere in this report as well as other risks and uncertainties could materially and adversely affect our business, operating results and financial condition. While management believes that the discussion and analysis in this report is adequate for a fair presentation of the information presented, we recommend that you read this discussion and analysis in conjunction with (i) our audited consolidated financial statements and notes thereto for the fiscal year ended December 28, 2013, which were included in our 2013 Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 7, 2014, and (ii) our other filings with the SEC.
We are an innovator in the field of metrology and inspection systems for semiconductor manufacturing and other industries. Our systems are designed to precisely monitor film thickness and critical dimensions that are necessary to control the manufacturing process and to identify defects that can affect production yields and performance.
Principal factors that impact our revenue growth include capital expenditures by manufacturers of semiconductors to increase capacity and to enable their development of new technologies, and our ability to gain market share. The increasing complexity of the manufacturing processes for semiconductors is an important factor in the demand for our innovative metrology systems, as are the adoption of optical critical dimension metrology across fabrication processes, the adoption of immersion lithography and double patterning, the adoption of new types of thin film materials, the adoption of advanced packaging strategies and wafer backside inspection, and the need for improved process control to drive process efficiencies. Our strategy is to continue to innovate organically as well as to evaluate strategic acquisitions to address business challenges and opportunities.
Our revenues are primarily derived from product sales but are also derived from customer service and system upgrades ("services'') for the installed base of our products. For the six months ended June 28, 2014, we derived 83% of our total net revenues from product sales and 17% of our total net revenues from services.

Overview

Nanometrics Incorporated, together with its subsidiaries, is a leading provider of advanced, high-performance process control metrology and inspection systems used primarily in the fabrication of integrated circuits, high-brightness LEDs (“HB-LED”), discrete components and data storage devices. Our automated and integrated systems address numerous process control applications, including critical dimension and film thickness measurement, device topography, defect inspection, overlay registration, and analysis of various other film properties such as optical, electrical and material characteristics. Our process control solutions are deployed throughout the fabrication process, from front-end-of-line substrate manufacturing, to high-volume production of semiconductors and other devices, to advanced wafer-scale packaging applications. Our systems enable device manufacturers to improve yields, increase productivity and lower their manufacturing costs. Our defect inspection systems locate large area and microscopic defects on patterned and unpatterned wafers. This system can be used for inspection at nearly every stage of the semiconductor production flow.


21


Nanometrics Products
We offer a diverse line of systems to address the broad range of process control requirements of the semiconductor manufacturing industry. In addition, we believe that our engineering expertise, strategic acquisitions, supplier alliances and short-cycle production strategies enable us to develop and offer advanced process control solutions in the future that should address industry advancement and trends. We categorize our systems as follows:
Automated Standalone Systems
Our automated systems are made up of both semi-automated and fully automated metrology systems which are employed in both high-volume and low-volume production environments. The Atlas® II, Atlas II+, Atlas XP/Atlas XP+ and Atlas-M represent our line of high-performance metrology systems providing optical critical dimension (“OCD”®), thin film metrology and wafer stress for transistor and interconnect metrology applications. The OCD technology is supported by our NanoCD® suite of solutions including our NanoDiffract® software and NanoGenTM scalable computing engine that enables visualization, modeling, and analysis of complex structures. The UniFireTM system enables users to measure multiple parameters at any given process step in the advanced packaging process flow for critical dimension, overlay, and topography applications. Our SPARKTM defect inspection system, offers ultra-fast inspection of patterned and unpatterned semiconductor wafers.
 
We continue to offer automated products for 200mm factories running at 90nm nodes and above, as well as systems supporting micro-electrical mechanical systems (“MEMS”).
System Platform
The Lynx® platform enables cluster metrology factory automation for improved cost of ownership to our customers by combining our Atlas® II and IMPULSE®, UniFire metrology and SPARK inspection systems in configurations to provide high throughput, reduced footprint systems for leading 300mm wafer metrology applications including OCD and thin film process control.
Integrated Systems
Our integrated metrology (“IM”) systems are installed directly onto wafer processing equipment to provide near real-time measurements for improved process control and maximum throughput. Our IM systems are sold directly to end customers and through OEM channels. The IMPULSE® system is our latest metrology platform for OCD and thin film metrology, and has been successfully qualified on numerous OEM platforms. Our 90x0 system is qualified for OEM and direct sales supporting thin film and OCD applications. Our NanoCD solutions suite is sold in conjunction with our IMPULSE® and legacy 90x0 systems. Our Trajectory® system provides in-line measurement of layers in thin film thickness and composition in semiconductor applications.
Materials Characterization
Our Materials Characterization products include systems that are used to monitor the physical, optical, electrical and material characteristics of discrete electronic industry, HB-LED, solar Photo-Voltaics ("PV"), compound semiconductor, strained silicon and silicon-on-insulator (“SOI”) devices, including composition, crystal structure, layer thickness, dopant concentration, contamination and electron mobility.
Our Vertex™ is a photoluminescence (“PL”) mapping system designed for high-volume compound semiconductor metrology applications including power control and photonics applications. The RPMBlue™ is our latest PL mapping system designed specifically for the HB-LED market. We sell Fourier-Transform Infrared (“FTIR”) automated and manual systems in the QS2200/3300 and QS1200 respectively. The FTIR systems are spectrometers designed for non-destructive wafer analysis for various applications. The NanoSpec® line, including the NanoSpec II products supporting thin film measurement across all applications in both low volume production and research applications.
We are continually working to strengthen our competitive position by developing new technologies and products in our market segment. In furtherance of our goals, we have:

Introduced new products in every core product line and primary market served;
 
Diversified our product line and addressed new markets through acquisitions, such as the 2011 acquisition of Nanda Technologies GmbH, a supplier of high sensitivity, high throughput defect inspection systems;
 
Continued development of new measurement and inspection technologies for advanced fabrication processes; and

22


 
Researched and developed innovative applications of existing technology to new market opportunities within the solar PV, HB-LED, and data storage industries.
Important Themes and Significant Trends
The semiconductor equipment industry is characterized by cyclical growth. Changing trends in the semiconductor industry continue to drive the need for metrology as a major component of manufacturing systems. These trends include:

Proliferation of Optical Critical Dimension Metrology across Fabrication Processes. Our customers use photolithographic processes to create patterns on wafers. Critical dimensions must be carefully controlled during this process. In advanced node device definition, additional monitoring of thickness and profile dimensions on these patterned structures at CMP, Etch, and Thin Film processing is driving broader OCD adoption. Our proprietary OCD systems can provide the critical process control of these circuit dimensions that is necessary for successful manufacturing of these state-of-the-art devices. Nanometrics OCD technology is broadly adopted across NAND, DRAM, HDD, and logic semiconductor manufacturing processes.
Adoption of Advanced Packaging Processes. Our customers use photolithographic, etching, metallization and wafer thinning to enable next generation advanced packaging solutions for semiconductor devices. The new packaging leads to increased functionality in smaller, less expensive form factors.  Advanced packages can be broken down into high density flip chip or bump packages that increase pin density allowing for more complex I/O on advanced CPU parts. Similar or different devices can be stacked at the wafer level using a Through Silicon Via ("TSV") process. The TSV process enables high density small form factor parts, being primarily driven by mobile consumer products (e.g. cellular telephones with integrated CMOS camera sensors). Increasingly advanced packaging technologies are being adopted by our end customers.
Adoption of New Types of Thin Film Materials. The need for ever increasing device circuit speed coupled with lower power consumption has pushed semiconductor device manufacturers to begin the replacement of the traditional aluminum etch back interconnect flows as well as conventional gate dielectric materials, all which drive a broader adoption of thin film and OCD metrology systems. To achieve greater semiconductor device speed, manufacturers have adopted copper in Logic/IDM and it is now proliferating in next generation DRAM and Flash nodes. Additionally, to achieve improved transistor performance in logic devices and higher cell densities in memory devices, new materials including high dielectric constant (or high-k) gate materials are increasingly being substituted for traditional silicon-oxide gate dielectric materials. High-k materials comprise complex thin films including layers of hafnium oxide and a bi-layer of thin film metals. Our advanced metrology and inspection solutions are required for control of process steps, which are critical to enable the device performance improvements that these new materials allow.
Development of 3D Transistor Architectures. Our end customers continue to improve device density and performance by scaling front end of line transistor architectures. Many of these designs, including fin-fet transistors and 3D-NAND have buried features and high aspect ratio stacked features that enable improved performance and density. The advanced designs require additional process control to manage the complex shapes and materials properties, driving additional applications for both OCD and our UniFire systems.
Need for Improved Process Control to Drive Process Efficiencies. Competitive forces influencing semiconductor device manufacturers, such as price-cutting and shorter product life cycles, place pressure on manufacturers to rapidly achieve production efficiency. Device manufacturers are using our integrated and automated systems throughout the fabrication to ensure that manufacturing processes scale rapidly, are accurate and can be repeated on a consistent basis.
Reduced Number of Customers. Our market is characterized by an ongoing oligopsonistic trend which drives customer concentration. Our largest customer accounted for 35% of our total revenue in the six months ended June 28, 2014, and 27% of our total revenue in the six months ended June 29, 2013.

Critical Accounting Policies
The preparation of our financial statements conforms to accounting principles generally accepted in the United States of America, which requires management, in applying our accounting policies, to make estimates and judgments that have an important impact on our reported amounts of assets, liabilities, revenue, expenses and related disclosures at the date of our financial statements. On an on-going basis, management evaluates its estimates including those related to bad debts, inventory valuations, warranty obligations, impairment and income taxes. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from management’s estimates. There were no significant changes in our critical accounting policies during the six months ended June 28, 2014. Please refer to Item 7, "Management's Discussion and Analysis of

23


Financial Condition and Results of Operations," in our Annual Report on Form 10-K for the fiscal year ended December 28, 2013 for a complete discussion of our critical accounting policies.
Recent Accounting Pronouncements
See Note 2 of the Unaudited Condensed Consolidated Financial Statements for a description of recent accounting pronouncements, including the respective dates of adoption and effects or anticipated effects on our results of operations and financial condition.

Results of Operations
Net Revenues
Our net revenues by category were as follows (in thousands, except percentages):

 
Three Months Ended
 
Six Months Ended
 
June 28,
2014
 
June 29,
2013
 
Changes In
 
June 28,
2014
 
June 29,
2013
 
Changes In
Amount
 
%
 
Amount
 
%
Automated Systems
$
33,456

 
$
23,366

 
$
10,090

 
43
%
 
$
67,339

 
$
28,628

 
$
38,711

 
135
 %
Integrated Systems
2,853

 
1,761

 
1,092

 
62
%
 
9,775

 
3,916

 
5,859

 
150
 %
Materials Characterization
2,915

 
1,406

 
1,509

 
107
%
 
5,390

 
7,068

 
(1,678
)
 
(24
)%
Total product revenues
39,224

 
26,533

 
12,691

 
48
%
 
82,504

 
39,612

 
42,892